Volume : 08, Issue : 01, January – 2021
137.SAFETY AND EFFICACY OF SENNA MAKKI IN THE TREATMENT OF THE CORONAVIRUS DISEASE 2019: A RETROSPECTIVE REVIEW
Dr Nazir Ahmed, Dr Saba Yaseen
Objective: To evaluate whether Senna Makki, used in conjunction with a plethora of other therapeutic agents, yields any added benefits in treating a COVID-19 infection.
Methods: A retrospective chart review of 1184 consecutive patients who used Senna Makki for a variable duration of their illness will be performed. Data pertaining to their age, comorbidities, disease presentation, and the eventual outcomes will be collated and analysed using the SPSS 25.0 statistical package.
Results: A total of 1184 patients were included in the study. The mean age of the patients was 37.5 years. Of those included, 25% had a prior history of diabetes while 18.5% of the patients reported one or more of the other comorbidities, including hypertension and coronary heart disease. Notably, the recovery rate was exorbitantly high, with almost all of the patients recovering after a variable duration of illness. The mean duration for which the Senna Makki treatment regimen was used was 12 days.
Conclusions: Used in conjunction with the vast array of therapeutic agents already available, Senna Makki might yield beneficial COVID-19 related outcomes.
Keywords : Senna Makki, COVID-19 infection and therapeutic agents.
Cite This Article:
Please cite this article in press Nazir Ahmed et al, Safety And Efficacy Of Senna Makki In The Treatment Of The Coronavirus Disease 2019: A Retrospective Review., Indo Am. J. P. Sci, 2021; 08.
Number of Downloads : 10